An international study published in the journal Proceedings of the National Academy of Sciences (PNAS) has recently concluded the fact of monitoring the drug dosage used in your lungs treatment.
The researchers are underway in developing a new method to effectively measure even the tiniest volume of drug which goes into the lungs during the treatment of long diseases.
This approach will safeguard the interests of the patients by controlling the affect of the drugs on the other organs of the body by helping you clinically lower the volume of drug needed for treatments and, thus, reduce their side effects. The physicians are required to deliver large amounts of the drug that may cause adverse effects to other organs in the body.
In this new method, micro-litres of liquid containing a drug are instilled into the lung, distributed as a thin film in the predetermined region of the lung airway, and absorbed locally, as reported by IANS.
“We envision that our micro-volume liquid instillation approach will enable predictable drug concentrations at the target site, reducing the amount of drug required for effective disease treatment with significantly reduced side effects,” said one of the researchers Gordana Vunjak-Novakovic, professor at the Columbia University in the US.
Lungs are susceptible to many diseases, including cystic fibrosis, bronchopneumonia, chronic obstructive pulmonary disease, and lung cancer, that are currently treated by systemic application of drugs, by oral intake, or aerosol inhalation.